Form 4: Gilead Sciences CFO Andrew Dickinson Awarded Stock and Restricted Stock Units
Executive Compensation Filing
Gilead Sciences' Chief Financial Officer, Andrew Dickinson, received stock and restricted stock units on December 10, 2024, as part of his compensation.
Summary
- Gilead Sciences, Inc. granted stock and restricted stock units to its Chief Financial Officer, Andrew D. Dickinson, on December 10, 2024.
- Mr. Dickinson received 3,640 shares of common stock.
- He was also granted 1,686 restricted stock units, each representing the right to receive one share of Gilead common stock.
- The restricted stock units vest over a four-year period, with 25% vesting on the first anniversary of the grant date and the remaining 75% vesting quarterly at a rate of 6.25%.
Sentiment
Score: 7
Explanation: The document reflects a standard compensation practice, which is generally positive for aligning management and shareholder interests. There are no negative implications.
Positives
- The grant of stock and restricted stock units aligns the CFO's interests with those of the shareholders.
- The vesting schedule of the restricted stock units encourages long-term commitment from the CFO.
Industry Context
Stock and restricted stock unit grants are a common form of compensation for executives in the pharmaceutical industry, aligning their interests with the long-term performance of the company.
Comparison to Industry Standards
- Stock-based compensation is a standard practice among large pharmaceutical companies like Gilead, such as Amgen, AbbVie, and Bristol Myers Squibb, to incentivize and retain key executives.
- The vesting schedule of four years with a cliff vest at one year followed by quarterly vesting is also a common practice in the industry.
Stakeholder Impact
- The stock and restricted stock unit grants align the CFO's interests with those of the shareholders, potentially leading to better long-term performance.
- The vesting schedule encourages the CFO's long-term commitment to the company.
Key Dates
| Date | Description |
|---|---|
| 2024-12-10 | Date of stock and restricted stock unit grant to Andrew D. Dickinson. |
| 2024-12-11 | Date of filing of the transaction. |
Keywords
Gilead Sciences, Andrew Dickinson, Chief Financial Officer, Stock Grant, Restricted Stock Units, Compensation, Vesting Schedule
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.